Greenwich LifeSciences In...

NASDAQ: GLSI · Real-Time Price · USD
12.11
0.03 (0.25%)
At close: Aug 15, 2025, 3:59 PM
12.17
0.50%
After-hours: Aug 15, 2025, 05:47 PM EDT

Greenwich LifeSciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-15.79M -8.89M -7.83M -4.57M
Depreciation & Amortization
3.61K 3.61K 3.61K 3.61K
Stock-Based Compensation
7.25M 2.38M 1.74M 660.58K
Other Working Capital
344.11K -3.97K -122.27K 141.57K
Other Non-Cash Items
n/a n/a 1.75M 1.19M
Deferred Income Tax
n/a n/a -1.75M -1.19M
Change in Working Capital
1.27M 31.5K -122.27K -385.17K
Operating Cash Flow
-7.27M -6.48M -6.2M -4.29M
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a -7.54M n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
4.37M n/a n/a 2.84M
Financial Cash Flow
4.37M n/a -7.54M 2.84M
Net Cash Flow
-2.9M -6.48M -13.74M -1.46M
Free Cash Flow
-7.27M -6.48M -6.2M -4.29M